Gaudium IVF raises Rs 49 crore in anchor round ahead of IPO opening tomorrow. Check key investors

Gaudium IVF and Women Health has raised Rs 49.5 crore from anchor investors ahead of the opening of its Rs 165 crore IPO, with allocations finalised at the upper end of the price band. The company's board approved the allocation of 62.65 lakh shares to four anchor investors at Rs 79 per share, including a premium of Rs 74 per share.

Meru Investment Fund PCC – Cell 1 received 21.51 lakh shares, accounting for 34.34% of the anchor portion, with an allocation worth Rs 16.99 crore. Sanshi Fund I was allotted 15.82 lakh shares, or 25.25% of the anchor book, translating into Rs 12.5 crore.

Hornbill Orchid India Fund secured 12.66 lakh shares, which is 20.21% of the anchor allocation and an investment of Rs 10 crore. Carnelian India Multi Strategy Fund was allotted 12.65 lakh shares, amounting to 20.2% of the anchor portion and Rs 10 crore in value.


The anchor placement comes a day before the public issue opens for subscription on February 20 and closes on February 24. The price band for the IPO has been fixed at Rs 75 to Rs 79 per share.

Gaudium IVF's IPO is a combination of a fresh issue of Rs 90 crore and an offer for sale of 94,93,700 shares worth Rs 75 crore, taking the total issue size to Rs 165 crore.

The net proceeds from the fresh issue are proposed to be used primarily for expansion and debt reduction. Around Rs 50 crore will be deployed towards setting up new IVF centres, while Rs 20 crore will go towards repayment or pre-payment of certain outstanding loans. The balance will be used for general corporate purposes.

Retail investors can apply for a minimum of 189 shares, requiring an investment of Rs 14,931 at the upper price band. The issue structure provides that not more than 50% of the net issue will be allocated to qualified institutional buyers, not less than 35% to retail investors, and not less than 15% to non-institutional investors.

Gaudium IVF and Women Health Ltd operates in the assisted reproductive technology segment, offering services such as IVF, ICSI, IUI and ovulation induction, along with gynaecological care and high-risk pregnancy management. The company follows a hub-and-spoke model and currently operates more than 30 locations, including seven hub centres and 28 spokes across India.

Financially, Gaudium IVF has reported steady growth. For the year ended March 2025, the company posted total income of Rs 70.96 crore and profit after tax of Rs 19.13 crore.